Carotenoids of microalgae used in food industry and medicine

Mini-Reviews in Medicinal Chemistry

Volumn 17, Issue 13, 2017, Pages 1140-1172

  Gateau, Hélène ^a   Solymosi, Katalin ^b   Marchand, Justine ^a   Schoefs, Benoît ^a  

^a UNIVERSITÉ DU MAINE   (France)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Astaxanthin; Cancer; Diatom; Food colorant; Fucoxanthin; Haematococcus; Health; carotene

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASTAXANTHIN; CAROTENOID; FOOD DYE; FUCOXANTHIN; XANTHOPHYLL;

BIOSYNTHESIS; CARDIOVASCULAR DISEASES; CHEMISTRY; METABOLISM; MICROALGA; NEOPLASMS; NEURODEGENERATIVE DISEASES; PATHOLOGY;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CAROTENOIDS; FOOD COLORING AGENTS; MICROALGAE; NEOPLASMS; NEURODEGENERATIVE DISEASES; XANTHOPHYLLS;

EID: 85043630893     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557516666160808123841     Document Type: Review

References (438)

1. Schoefs, B. Chlorophyll and carotenoid analysis in food products. Part II. A case by case. Trends Anal. Chem., 2003, 22, 335-339.
2. Schoefs, B. Determination of pigments in vegetables. J. Chromatogr. A, 2004, 1054, 217-226.
3. Long, S.P.; Marshall-Lolon, A.; Zhu, X.-G. Meeting the global food demand of the future by engineering crop photosynthesis and field potential. Cell, 2015, 161, 56-66.
4. Miyawaki, H.; Takahashi, J.; Tsukahara, H.; Takehara, I. Effects of astaxanthin in human blood rheology. J. Chim. Biochem. Nutr., 2008, 43, 69-74.
5. Aoi, W.; Naito, Y.; Sakuma, K.; Kuchide, M.; Tokuda, H.; Maoka, T.; Toyokumi, S.; Oka, S.; Yasuhara, M.; Yoshikawa, T. Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid. Redox Signal., 2003, 5(1), 139-144.
6. Martin, C.; Zhang, Y.; Tonelli, C.; Petroni, K. Plants, diet, and health. Annu. Rev. Plant Biol., 2013, 64, 19-46.
7. Leu, S.; Boussiba, S. Advances in the production of high-value products by microalgae. Ind. Biotech., 2014, 10, 169-183.
8. Delgado-Vargas, F.; Jiménez, A.R.; Paredes-Lopez, O. Natural pigments: Carotenoids, anthocyanins, and betalains -characteristics, biosynthesis, processing, and stability. Crit. Rev. Food Sci. Nutr., 2000, 40, 173-289.
9. Alexandratos, N.; Bruinsma, J. World Agriculture Towards 2030/2050: The 2012 revision; ESA Working paper, FAO: Rome, 2012.
10. Fernandez-Sevilla, J.M.; Acien Fernandez, F.G.; Molina Grima, E. Biotechnological production of lutein and its applications. Appl. Microbiol. Biotechnol., 2010, 86, 27-40.
11. Lemoine, Y.; Schoefs, B. Secondary ketocarotenoid astaxanthin biosynthesis in algae: a multifunctional response to stress. Photosynth. Res., 2010, 106, 155-177.
12. Mimouni, V.; Ulmann, L.; Pasquet, V.; Mathieu, M.; Picot, L.; Bougaran, G.; Cadoret, J.-P.; Morant-Manceau, A.; Schoefs, B. The potential of microalgae for the production of bioactive molecules of pharmaceutical interest. Curr. Pharm. Biotechnol., 2012, 13(15), 2733-2750.
13. Heydarizadeh, P.; Poirier, I.; Loizeau, D.; Ulmann, L.; Mimouni, V.; Schoefs, B.; Bertrand, M. Plastids of marine phytoplankton produce bioactive pigments and lipids. Mar. Drugs, 2013, 11, 3425-3471.
14. Guiry, M. How many species of algae are there? J. Phycol., 2012, 48, 1057-1063.
15. Schoefs, B. Progress in diatom research: From taxonomy to physiology. Diatom Res., 2014, 29, 3-4.
16. Vinayak, V.; Gordon, R.; Gautam, S.; Rai, A. Discovery of a diatom that oozes oil. Adv. Sci. Lett., 2014, 20, 1256-1267.
17. Vinayak, V.; Manoylov, K.M.; Gateau, H.; Blanckaert, V.; Penchreac'h, G.; Hérault, J.; Marchand, J.; Gordon, R.; Schoefs, B. Diatom milking: A review and new approaches. Mar. Drugs, 2015, 13, 2629-2665.
18. Beauger, A.; Serieyssol, K.; Schoefs, B. Recent progress in diatom’s taxonomy and freshwater ecology. Cryptogamie Algol., 2015, 36, 241-244.
19. Takaichi, S. Carotenoids in algae: Distributions, biosyntheses and functions. Mar. Drugs, 2011, 9(6), 1101-1118.
20. Christaki, E.; Bonos, E.; Giannenas, I.; Florou_Paneri, P. Functional properties of carotenoids originating from algae. J. Sci. Food Agric., 2013, 93(1), 5-11.
21. Britton, G.; Liaanen-Jensen, S.; Pfander, H. Carotenoids. Nutrition and Health, Birkhäuser: Basel, Vol 5, 2009.
22. Del Campo, J.A.; Garcia Gonzalez, M.; Guerrero, M.G. Outdoor cultivation of microalgae for carotenoid production: Current state and perspectives. Appl. Microbiol. Biotechnol., 2007, 74, 1163-1174.
23. Ghosh, T.; Paliwal, C.; Maurya, R.; Mishra, S. In: Plant Biology and Biotechnology: Volume I: Plant Diversity, 777 Organization, Function and Improvement; Bahadur, B., Rajam, M.V., Sahijram, L., Krishnamurthy, K.V., Eds.; Springer: New Delhi, 2015; Vol. I, pp. 777-791.
24. Solovchenko, A.E.; Khozin-Goldberg, I.; Didi-Cohen, S.; Cohen, Z.; Merzlyak, M.N. Effects of light and nitrogen starvation on the content and composition of carotenoids of the green microalga Parietochloris incisa. Russ. J. Plant Physiol., 2008, 55(4), 455-462.
25. Rodriguez-Saiz, M.; de la Fuente, J.L.; Barredo, J.L. Xanthophyllomyces dendrorhous for the industrial production of astaxanthin. Appl. Microbiol. Biotechnol., 2010, 88, 645-658.
26. Schmidt, I.; Schewe, H.; Gassel, S.; Jin, C.; Buckingham, J.; Hümbelin, M.; Sandmann, G.; Schraber, J. Biotechnological production of astaxanthin with Phaffia rhodozyma/Xanthophyllomyces dendrorhous. Appl. Microbiol. Biotechnol., 2011, 89, 555-571.
27. Kopecky, J.; Stys, D.; Loetz, K.; Poulz, O.; Schoefs, B. Microalgae as a source for secondary carotenoid production. A screening study. Arch. Hydrobiol. Algol. Stud., 2000, 98, 153-167.
28. Ranga Rao, A.; Raghunath Reddy, R.L.; Baskaran, V.; Sarada, R.; Ravishankar, G.A. Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model. J. Agric. Food Chem., 2010, 58(15), 8553-8559.
29. Del Campo, J.A.; Rodriguez, H.; Moreno, J.; Vargas, M.A.; Rivas, J.; Guerrerro, M.G. Accumulation of astaxanthin and lutein in Chlorella zofingiensis (Chlorophyta). Appl. Microbiol. Biotechnol., 2004, 64, 848-854.
30. Orosa, M.; Torres, E.; Fidalgo, P.; Abalde, J. Production and analysis of secondary carotenoids in green algae. J. Appl. Phycol., 2000, 12, 553-556.
31. Zhang, D.H.; Lee, Y.K. Enhanced accumulation of secondary carotenoids in a mutant of the green alga, Chlorococcum sp. J. Appl. Phycol., 1997, 9, 459-463.
32. Durmaz, Y.; Donato, M.; Monteiro, M.; Gouveia, L.; Nunes, M.L.; Pereira, T.G.; Gökpinar, S.; Bandarra, N.M. Effect of temperature on α-tocopherol, fatty acid profile, and pigments of Diacronema vlkianum (Haptophyceae). Aquacult. Int., 2009, 17(4), 391-399.
33. Veiga-Crespo, P.; Blasco, L.; dos Santos, F.R.; Poza, M.; Villa, T.G. Influence of culture conditions of Gordonia jacobaea MV-26 on canthaxanthin production. Intl. Microbiol., 2005, 8, 55-58.
34. Shahidi, F.; Brown, J.A. Carotenoid pigments in seafoods and aquaculture. Crit. Rev. Food Sci., 1998, 38, 1-67.
35. Kim, S.; Jung, Y.-J.; Kwon, O.-N.; Cha, K.; Um, B.-H.; Chung, D.; Pan, C.-H. Potential commercial source of fucoxanthin extracted from the microalga Phaeodactylum tricornutum. Appl. Biochem. Biotechnol., 2012, 166, 1843-1855.
36. Li, Z.; Sun, M.; Li, Q.; Li, A.; Zhang, C. Profiling of carotenoids in six microalgae (Eustigmatophyceae) and assessment of their β-carotene productions in bubble column photobioreactor. Biotechnol. Lett., 2012, 34, 2049-2053.
37. Li, Z.; Ma, X.; Li, A.; Zhang, C. A novel potential source of β-carotene: Eustigmatos cf. polyphem (Eustigmatophyceae) and pilot β-carotene production in bubble column and flat panel photobioreactors. Bioresour. Technol., 2012, 117, 257-263.
38. Lin, J-H.; Lee, D-J.; Chang, J-S. Lutein production from biomass: marigold flowers versus microalgae. Bioresour. Technol., 2015, 184, 421-428.
39. Dineshkumar, R.; Dhanarajan, G.; Dash, S.K.; Sen, R. An advanced hybrid medium optimization strategy for the enhanced productivity of lutein in Chlorella minutissima. Algal Res., 2015, 7, 24-32.
40. Yoshii, Y.; Takaichi, S.; Maoka, T.; Suda, S.; Sekiguchi, H.; Nakayama, T.; Inoue, I. Variation of siphonaxanthin series among the genus Nephroselmis (Prasinophyceae, Chlorophyta), including a novel primary methoxy carotenoid. J. Phycol., 2005, 41, 827-834.
41. Ernst, H. Recent advances in industrial carotenoid synthesis. Pure Appl. Chem., 2002, 74(8), 1369-1382.
42. Sajilata, M.G.; Singhal, R.S.; Kamat, M.Y. The carotenoid pigment zeaxanthin-a review. Compr. Rev. Food Sci. Food Saf., 2008, 7, 29-49.
43. Cuaresma, M.; Casal, C.; Forján, E.; Vílchez, C. Productivity and selective accumulation of carotenoids of the novel extremophile microalga Chlamydomonas acidophila grown with different carbon sources in batch systems. J. Ind. Microbiol. Biotechnol., 2011, 38, 167-177.
44. Schoefs, B. Plant pigments: Properties, analysis, degradation. Adv. Food Nutr. Res., 2005, 49, 41-91.
45. Solymosi, K.; Latruffe, N.; Morant-Manceau, A.; Schoefs, B. In: Colour Additives for Foods and Beverages: Development, Safety and Applications; Scotter, M., Ed. Woodhead Publishing: Amsterdam, 2015, pp. 1-34.
46. Kang, S.-L.; Ko, H.-C.; Shin, H.-S.; Kim, H.-M.; Hong, Y.-S.; Lee, N.H.; Kim, S. Fucoxanthin exerts different effects on 3T3-L1 cells according to differentiation stage and inhibits glucose uptake in mature adipocytes. Biochem. Biophys. Res. Commun., 2011, 409, 769-774.
47. Gagez, A.L; Thiery, V.; Pasquet, V.; Cadoret, J.P.; Picot, L. Epoxycarotenoids and cancer (review). Curr. Bioactive Comp., 2012, 8(2), 109-141, 2012.
48. Heo, S.-J.; Yoon, W.-S.; Kim, K.-N.; Oh, C.; Choi, Y.-U.; Yoon, K.-T.; Kang, D.-H.; Qian, Z.-J.; Chai, I.-W.; Junk, W.-K. Antiinflammatory effect of fucoxanthin derivatives isolated from Sargassum siliquastrum in lipopolysaccharide-stimulated RAW 264.7 macrophage. Food Chem. Toxicol., 2012, 50, 3336-3342.
49. Everts, S. Note-by-note cuisine. Chem. Engin. News, 2012, 90(46), 33.
50. Scotter, M.J. Colour Additives for Food and Beverages: Development, Safety and Applications, Woodhead Publishing: Amsterdam, 2015.
51. Moran, N.A.; Jarvik, T. Lateral transfer of genes from fungi underlies carotenoids production in aphids. Science, 2010, 328(5978), 624-627.
52. Altincinek, B.; Kovacs, J.L.; Gerardo, N.M. Horizontally transferred fungal carotenoid genes in the two-spotted spider mite Tetranychus urticae. Biol. Lett., 2012, 8, 253-257.
53. Eroglu, A.; Harrison, E.H. Carotenoid metabolism in mammals, including man: Formation, occurrence, and function of apocarotenoids. J. Lipid Res., 2013, 54(7), 1719-1730.
54. Cazzonelli, C.I. Carotenoids in nature: Insights from plants and beyond. Funct. Plant Biol., 2011, 38(11), 833-847.
55. Britton, G. Structure and properties of carotenoids in relation to function. FASEB J., 1995, 9(15), 1551-1558.
56. Britton, G.; Liaanen-Jensen, S.; Pfander, H. Carotenoids Handbook, Birkhäuser: Basel, 2004.
57. Mortensen, A. Carotenoids and other pigments as natural colorants. Pure Appl. Chem., 2006, 78, 1477-1491.
58. Schoefs, B. Chlorophyll and carotenoid analysis in food products. Properties of the pigments and methods of analysis. Trends Food Sci. Technol., 2002, 13, 361-371.
59. Nakazawa, Y.; Sashima, T.; Hosokawa, M.; Miyashita, K. Comparative evaluation of growth inhibitory effect of stereoisomers of fucoxanthin in human cancer cell lines. J. Funct. Foods, 2009, 1(1), 88-97.
60. Schoefs, B.; Lemoine, Y.; Bertrand, M. Reversed-phase highperformance liquid chromatography separation of photosynthetic pigments and their precursors. Amer. Biotechnol. Lab., 1996, 14, 18-22.
61. Pfeil, B.; Schoefs, B.; Spetea, C. Function and evolution of channels and transporters in photosynthetic membranes. Cell. Mol. Life Sci., 2014, 71, 979-998.
62. Miyashita, K.; Nishikawa, S.; Beppu, F.; Tsukui, T.; Abe, M.; Hosokawa, M. The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds. J. Sci. Food Agric., 2011, 91, 1166-1174.
63. Ruzicka, L. The isoprene rule and the biogenesis of terpenic compounds. Experientia, 1953, 9, 353-367.
64. Rohmer, M. The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat. Prod. Rep., 1999, 16(5), 565-574.
65. Bertrand, M. Carotenoid biosynthesis in diatoms. Photosynth. Res., 2010, 106(1-2), 89-102.
66. Domonkos, I.; Kis, M.; Gombos, Z.; Ughy, B. Carotenoids, versatile components of oxygenic photosynthesis. Prog. Lipid Res., 2013, 52, 539-561.
67. Eisenreich, W.; Scharz, M.; Cartayrade, A.; Arigoni, D.; Zenk, M.H.; Bacher, A. The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms. Chem. Biol., 1998, 5, 221-233.
68. Lichtenthaler, H.K. The 1-deoxy-D-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plants. Ann. Rev. Plant Physiol. Plant Mol. Biol., 1999, 50, 47-65.
69. Massé, G.; Belt, S.T.; Rowland, S.J.; Rohmer, M. Isoprenoid biosynthesis in the diatoms Rhizosolenia setigera (Brightwell) and Haslea ostrearia (Simonsen). Proc. Natl. Acad. Sci. USA, 2004, 101, 4413-4418.
70. Lombard, J.; Moreira, D. Origins and early evolution of the mevalonate pathway of isoprenoid biosynthesis in the three domains of life. Mol. Biol. Evol., 2011, 28, 87-99.
71. Wilson, R.J.M. Progress with parasite plastids. J. Mol. Biol., 2002, 319, 257-274.
72. Voynova, N.E.; Rios, S.E.; Miziorko, H.M. Staphylococcus aureus mevalonate kinase: isolation and characterization of an enzyme of the isoprenoid biosynthetic pathway. J. Bacteriol., 2004, 186, 61-67.
73. Steussy, C.N.; Robison, A.D.; Tetrick, A.M.; Knight, J.T.; Rodwell, V.W.; Stauffacher, C.V.; Sutherlin, A.L. A structural limitation on enzyme activity: The case of HMG-CoA synthase. Biochemistry, 2006, 45, 14407-14414.
74. Bisanz, C.; Botté, C.; Saïdani, N.; Bastien, O.; Cesbron-Delauw, M.-F.; Maréchal, E. In: Plant Cell Compartments -Selected Topics; Schoefs, B., Ed.; Research Signpost: Trivandrum, 2008; pp. 393-423.
75. Solymosi, K. Plastid structure, diversification and interconversions. I. Algae. Curr. Chem. Biol., 2012, 6(3), 167-186.
76. Solymosi, K.; Keresztes, Á. Plastid structure, diversification and interconversions. I. Land plants. Curr. Chem. Biol., 2012, 6(3), 187-204.
77. Lange, B.M.; Rujan, T.; Martin, W.; Croteau, R. Isoprenoid biosynthesis: The evolution of two ancient and distinct pathways across genomes. Proc. Natl. Acad. Sci. USA, 2000, 97, 13172-13177.
78. 2 as main carbon source for isoprenoid biosynthesis via the mevalonate-independent methylerythritol 4-phosphate route in the marine diatoms Phaeodactylum tricornutum and Nitzschia ovalis. Phytochemistry, 2000, 53(1), 21-28.
79. Nabeta, K.; Kawae, T.; Kikuchi, T.; Saitoh, T.; Oluyama, H. Biosynthesis of chlorophyll a from 13C-labelled mevalonates and glycine in liverwort. Nonequivalent labelling of phytyl side chain. Chem. Commun., 1995, 24, 2529-2530.
80. Schwender, J.; Seemann, M.; Lichtenthaler, H.K.; Rohmer, M. Biosynthesis of isoprenoids (carotenoids, sterols, prenyl side-chains of chlorophylls and plastoquinone) via a novel pyruvate/ glyceraldehyde 3-phosphate non-mevalonate pathway in the green alga Scenedesmus obliquus. Biochem. J., 1996, 316, 73-80.
81. Disch, A.; Schwender, J.; Müller, C.; Lichtenthaler, H.K.; Röhmer, M. Distribution of the mevalonate and glyceraldehyde phosphate/ pyruvate pathways for isoprenoid biosynthesis in unicellular algae and the cyanobacterium Synechocystis PCC 6714. Biochem. J., 1988, 333, 381-388.
82. Maurey, K.; Wolf, F.; Golbeck, J. 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in Ochromonas malhamensis: A system to study the relationship between enzyme activity and rate of steroid biosynthesis. Plant Physiol., 1986, 82(2), 523-527.
83. Lee, P.C.; Schmidt-Dannert, C. Metabolic engineering towards biotechnological productions of carotenoids in microorganisms. Appl. Microbiol. Biotechnol., 2002, 60, 1-11.
84. Mojaat, M.; Pruvost, J.; Foucault, A.; Legrand, J. Effect of organic carbon sources and Fe2+ ions on growth and β-carotene accumulation by Dunaliella salina. Biochem. Eng. J., 2008, 39, 177-184.
85. Schoefs, B.; Rmiki, N.; Rachidi, J.; Lemoine, Y. Astaxanthin synthesis in Haematococcus pluvialis requires a cytochrome P450-dependent hydroxylase and an active synthesis of fatty acids. FEBS Lett., 2001, 500, 125-128.
86. Moulin, P.; Lemoine, Y.; Schoefs, B. In: Handbook of Plant and Crop Stress, 3rd Ed.; Pessarakli, M., Ed.; Taylor and Francis: New York, 2010; pp. 407-433.
87. Ip, F.P.; Chen, F. Employment of reactive oxygen species to enhance astaxanthin formation in Chlorella zofingiensis in heterotrophic cultures. Process Biochem., 2005, 40, 3491-3496.
88. Masmoudi, S.; Nguyen-Deroche, N.; Caruso, A.; Ayadi, H.; Morant-Manceau, A.; Tremblin, G.; Bertrand, M.; Schoefs, B. Metals in diatoms: From heaven to hell -a review. Cryptogamie Algol., 2013, 34, 185-225.
89. Yu, X.; Cui, H.; Cui, Y.; Wang, Y.; Li, X.; Liu, Z.; Qin, S. Gene cloning, sequence analysis, and expression profiles of a novel β-ring carotenoid hydroxylase gene from the photoheterotrophic green alga Chlorella kessleri. Mol. Biol. Rep., 2014, 41, 7103-7113.
90. Kirilovsky, D. Dissipating energy by carotenoids. Nat. Chem. Biol., 2015, 11, 242-243.
91. Bode, S.; Quentmeier, C.C.; Liao, P.N.; Hafi, N.; Barros, T.; Wilk, L.; Bittner, F.; Walla P.J. On the regulation of photosynthesis by excitonic interactions between carotenoids and chlorophylls. Proc. Natl. Acad. Sci. USA, 2009, 106(30), 12311-12316.
92. Holt, N.E.; Zigmantas, D.; Valkunas, L.; Li, X.-P.; Niyogi, K.K.; Fleming, G.R. Carotenoid cation formation and the regulation of photosynthetic light harvesting. Science, 2005, 307, 433-436.
93. Ruban, A.V.; Berera, R.; Ilioaia, C.; van Stokkum, I.H.M.; Kennis, J.T.M.; Pascal, A.A.; van Amerongen, H.; Robert, B.; Horton, P.; van Grondelle, R. Identification of a mechanism of photoprotective energy dissipation in higher plants. Nature, 2007, 450, 575-578.
94. Staleva, H.; Komenda, J.; Shukla, M.; Slouf, V.; Kana, R.; Polivka, T.; Sobotka, R. Mechanism of photoprotection in the cyanobacterial ancestor of plant antenna proteins. Nat. Chem. Biol., 2015, 11, 287-292.
95. Domozych, D.S.; Sørensen, I.; Willats, W.G.T. The distribution of cell wall polymers during antheridium development and spermatogenesis in the Charophycean green alga Chara corallina. Ann. Bot., 2009, 104, 1045-1056.
96. Ferruzzi, M.G.; Failla, M.; Schwartz, S.J. Assessment of degradation and intestinal cell uptake of chlorophyll derivatives from spinach puree using an in vitro digestion and Caco-2 human cell model. J. Agric. Food Chem., 2001, 9, 2082-2089.
97. van Bennekum, A.; Werder, M.; Thuahnai, S.T.; Han, C.-H.; Duong, P.; Williams, D.L.; Wettstein, P.; Schulthess, G.; Phillips, M.C. Class B scavenger receptor-mediated intestinal absorption of dietary β-carotene and cholesterol. Biochemistry, 2005, 44(11), 4517-4525.
98. Heo, J.; Kim, S.H.; Lee, P.C. New insight into the cleavage reaction of Nostoc sp. strain PCC 7120 carotenoid cleavage dioxygenase in natural and nonnatural carotenoids. Appl. Environ. Microbiol., 2013, 79(11), 3336-3345.
99. Ambati, R.R.; Phang, S.-M.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications -a review. Mar. Drugs, 2014, 12, 128-152.
100. Stahl, W.; Junghans, A.; de Boer, B.; Driomina, E.S.; Briviba, K.; Sies, H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett., 1998, 427(2), 305-308.
101. Stahl, W.; Sies, H. Bioactivity and protective effects of natural carotenoids. Biochim. Biophys. Acta, 2005, 1740(2), 101-107.
102. Steenbock, H. White corn vs. yellow corn and a probable relationship between the fat soluble vitamins and yellow plant pigments. Science, 1919, 50, 352-353.
103. Lakshman, M.R. Alpha and omega of carotenoid cleavage. J. Nutr., 2010, 134(2), 241S-245S.
104. Faure, H.; Fayol, V.; Galabert, C.; Grolier, P.; Le Moel, G.; Steghens, J.P.; Nabet, F. Les caroténoïdes: 1. Métabolisme et physiologie. Ann. Biol. Clin., 1999, 57, 169-183.
105. Carrillo-Lopez, A.; Yahia, E.M.; Ramirez-Padilla, G.K. Bioconversion of carotenoids in five fruits and vegetables to vitamin A measured by retinol accumulation in rat livers. Am. J. Agric. Biol. Sci., 2010, 5(2), 215-221.
106. Zeb, A.; Mehmood, S. Carotenoids contents from various sources and their potential health applications. Pak. J. Nutr., 2004, 3(3), 199-204.
107. Tanumihardjo, S.A. Factors influencing the conversion of carotenoids to retinol: Bioavailability to bioconversion to bioefficacy. Int. J. Vit. Nutr. Res., 2002, 72(1), 40-45.
108. Nagao, A.; Olson, J.A. Enzymatic formation of 9-cis, 13-cis, and all trans retinals from isomers of β-carotene. FASEB J., 1994, 8, 968-973.
109. Heyman, R.A.; Mangelsdorf, D.J.; Dyck, J.A.; Stein, R.B.; Eichele, G.; Evans, R.M.; Thaller, C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 1992, 68, 397-406.
110. Deming, D.M.; Teixeira, S.R.; Erdman, J.W. Jr. All-trans β-carotene appears to be more bioavailable than 9-cis or 13-cis β-carotene in gerbils given single oral doses of each isomer J. Nutr., 2002, 132(9), 2700-2708.
111. National Research Council. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc; The National Academies Press: Washington, 2001.
112. Borowitzka, M.A. Commercial production of microalgae: Ponds, tanks, tubes and fermenters. J. Biotechnol., 1999, 70(1), 313-321.
113. Spolaore, P.; Joannis-Cassan, C.; Duran, E.; Isambert, A. Commercial applications of microalgae. J. Biosci. Bioeng., 2006, 101(2), 87-96.
114. Tang, G.; Suter, P.M. Vitamin A, nutrition, and health values of algae: Spirulina, Chlorella, and Dunaliella. J. Pharm. Nutr. Sci., 2011, 1(2), 111-118.
115. Thinakar V.; von der Weid, D.; Edwin N. “Spirulina, a nutrition booster.” 7th World Congress on Clinical Nutrition, New Delhi, India, 1999. (http://www.antennaindia.org/thinakar.html).
116. Priyadarshani, I.; Rath, B. Commercial and industrial applications of microalgae -A review. J. Algal Biomass Utln., 2012, 3(4), 89-100.
117. Finkel, T. Oxygen radicals and signaling. Curr. Opin. Cell Biol., 1998, 10(2), 248-253.
118. Pashkow, F.J.; Watumull, D.G.; Campbell, C.L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol., 2008, 101(10), S58-S68.
119. Nishikawa, T.; Edelstein, D.; Du, X.L.; Yamagishi, S.I.; Matsumura, T.; Kaneda, Y.; Brownlee, M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 2000, 404(6779), 787-790.
120. Nemoto, S.; Takeda, K.; Yu, Z.X.; Ferrans, V.J.; Finkel, T. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol. Cell. Biol., 2000, 20(19), 7311-7318.
121. Papas, A.M. Determinants of antioxidant status in humans. Lipids, 1996, 31(1), S77-S82.
122. Johnson, E.J. The role of carotenoids in human health. Nutr. Clinic. Care, 2002, 5(2), 56-65.
123. Agarwal, S.; Rao, A.V. Tomato lycopene and its role in human health and chronic diseases. Can. Med. Assoc. J., 2000, 163(6), 739-744.
124. Elliott, R. Mechanisms of genomic and non-genomic actions of carotenoids. Biochim. Biophys. Acta, 2005, 1740(2), 147-154.
125. Ngo, D.H.; Wijesekara, I.; Vo, T.S.; Van Ta, Q.; Kim, S.K. Marine food-derived functional ingredients as potential antioxidants in the food industry: An overview. Food Res. Int., 2011, 44(2), 523-529.
126. Sies, H.; Stahl, W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr., 1995, 62(6), 1315S-1321S.
127. Murthy, K.C.; Vanitha, A.; Rajesha, J.; Swamy, M.M.; Sowmya, P.R.; Ravishankar, G.A. In vivo antioxidant activity of carotenoids from Dunaliella salina -a green microalga. Life Sci., 2005, 76(12), 1381-1390.
128. Levin, G.; Mokady, S. Antioxidant activity of 9-cis compared to all-trans-β-carotene in vitro. Free Radic. Biol. Med., 1994, 17(1), 77-82.
129. Li, H.B.; Cheng, K.W.; Wong, C.C.; Fan, K.W.; Chen, F.; Jiang, Y. Evaluation of antioxidant capacity and total phenolic content of different fractions of selected microalgae. Food Chem., 2007, 102(3), 771-776.
130. Dambeck, M.; Sandmann, G. Antioxidative activities of algal keto carotenoids acting as antioxidative protectants in the chloroplast. Photochem. Photobiol., 2014, 90(4), 814-819.
131. Paiva, S.A.; Russell, R.M. β-Carotene and other carotenoids as antioxidants. J. Am. Coll. Nutr., 1999, 18(5), 426-433.
132. Skibsted, L.H. Carotenoids in antioxidant networks. Colorants or radical scavengers. J. Agric. Food Chem., 2012, 60(10), 2409-2417.
133. Truscott, T.G. New trends in photobiology: The photophysics and photochemistry of the carotenoids. J. Photochem. Photobiol. B:Biol., 1990, 6(4), 359-371.
134. Young, A.J.; Lowe, G.M. Antioxidant and prooxidant properties of carotenoids. Arch. Biochem. Biophys., 2001, 385(1), 20-27.
135. Martin, H.D.; Jäger, C.; Ruck, C.; Schmidt, M.; Walsh, R.; Paust, J. Anti_and prooxidant properties of carotenoids. J. Prakt. Chem., 1999, 341(3), 302-308.
136. Rodrigues, E.; Mariutti, L.R.; Mercadante, A.Z. Scavenging capacity of marine carotenoids against reactive oxygen and nitrogen species in a membrane-mimicking system. Mar. Drugs, 2012, 10(8), 1784-1798.
137. Zhang, J.; Sun, Z.; Sun, P.; Chen, T.; Chen, F. Microalgal carotenoids: Beneficial effects and potential in human health. Food Funct., 2014, 5(3), 413-425.
138. Hussein, G.; Goto, H.; Oda, S.; Sankawa, U.; Matsumoto, K.; Watanabe, H. Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biol. Pharm. Bull., 2006, 29(4), 684-688.
139. Hussein, G.; Sankawa, U.; Goto, H.; Matsumoto, K.; Watanabe, H. Astaxanthin, a carotenoid with potential in human health and nutrition. J. Nat. Prod., 2006, 69(3), 443-449.
140. McNulty, H.P.; Byun, J.; Lockwood, S.F.; Jacob, R.F.; Mason, R.P. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim. Biophys. Acta, 2007, 1768(1), 167-174.
141. Gouveia, L.; Batista, A.P.; Sousa, I.; Raymundo, A.; Bandarra, N.M. In: Food Chemistry Research Developments; Papadopoulos, K.N., Ed.; Nova Science Publishers: New York, 2008; pp. 1-37.
142. Augusti, P.R.; Quatrin, A.; Somacal, S.; Conterato, G.M.; Sobieski, R.; Ruviaro, A.R.; Emanuelli, T. Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits. J. Clin. Biochem. Nutr., 2012, 51(1), 42-49.
143. Kamath, B.S.; Srikanta, B.M.; Dharmesh, S.M.; Sarada, R.; Ravishankar, G.A. Ulcer preventive and antioxidative properties of astaxanthin from Haematococcus pluvialis. Eur. J. Pharmacol., 2008, 590(1-3), 387-395.
144. Nomura, T.; Kikuchi, M.; Kubodera, A.; Kawakami, Y. Proton_donative antioxidant activity of fucoxanthin with 1,1_diphenyl_2_picrylhydrazyl (DPPH). IUBMB Life, 1997, 42(2), 361-370.
145. Sachindra, N.M.; Sato, E.; Maeda, H.; Hosokawa, M.; Niwano, Y.; Kohno, M.; Miyashita, K. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J. Agric. Food Chem., 2007, 55(21), 8516-8522.
146. Peng, J.; Yuan, J.P.; Wu, C.F.; Wang, J.H. Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: Metabolism and bioactivities relevant to human health. Mar. Drugs, 2011, 9(10), 1806-1828.
147. Böhm, F.; Edge, R.; Lange, L.; Truscott, T.G. Enhanced protection of human cells against ultraviolet light by antioxidant combinations involving dietary carotenoids. J. Photochem. Photobiol. B: Biol., 1998, 44(3), 211-215.
148. Palozza, P.; Krinsky, N.I. β-Carotene and α-tocopherol are synergistic antioxidants. Arch. Biochem. Biophys., 1992, 297(1), 184-187.
149. Libby, P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr. Rev., 2007, 65(S3), S140-S146.
150. Pan, M.H.; Lai, C.S.; Dushenkov, S.; Ho, C.T. Modulation of inflammatory genes by natural dietary bioactive compounds. J. Agric. Food Chem., 2009, 57(11), 4467-4477.
151. Soontornchaiboon, W.; Joo, S.S.; Kim, S.M. Anti-inflammatory effects of violaxanthin isolated from microalga Chlorella ellipsoidea in RAW 264.7 macrophages. Biol. Pharm. Bull., 2012, 35(7), 1137-1144.
152. Lee, S.J.; Bai, S.K.; Lee, K.S.; Namkoong, S.; Na, H.J.; Ha, K.S.; Han, J.A.; Yim, S.V.; Chang, K.; Kwon, Y.G.; Lee, S.K.; Kim, Y.M. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation. Mol. Cells, 2003, 16(1), 97-105.
153. Salminen, A.; Lehtonen, M.; Suuronen, T.; Kaarniranta, K.; Huuskonen, J. Terpenoids: Natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell. Mol. Life Sci., 2008, 65(19), 2979-2999.
154. Yang, D.J.; Lin, J.T.; Chen, Y.C.; Liu, S.C.; Lu, F.J.; Chang, T.J.; Chang, Y.Y. Suppressive effect of carotenoid extract of Dunaliella salina alga on production of LPS-stimulated pro-inflammatory mediators in RAW264.7 cells via NF-κB and JNK inactivation. J. Funct. Foods, 2013, 5(2), 607-615.
155. Izumi-Nagai, K.; Nagai, N.; Ohgami, K.; Satofuka, S.; Ozawa, Y.; Tsubota, K.; Ishida, S. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscl. Throm. Vas., 2007, 27(12), 2555-2562.
156. Jin, X.H.; Ohgami, K.; Shiratori, K.; Suzuki, Y.; Hirano, T.; Koyama, Y.; Ohno, S. Inhibitory effects of lutein on endotoxininduced uveitis in Lewis rats. Investig. Ophthalmol. Visual Sci., 2006, 47(6), 2562-2568.
157. Bai, S.K.; Lee, S.J.; Na, H.J.; Ha, K.S.; Han, J.A.; Lee, H.; Kim, Y.M. β-carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redoxbased NF-κB activation. Exp. Mol. Med., 2005, 37(4), 323-334.
158. Kim, K.N.; Heo, S.J.; Yoon, W.J.; Kang, S.M.; Ahn, G.; Yi, T.H.; Jeon, Y.J. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur. J. Pharmacol., 2010, 649(1), 369-375.
159. Konishi, I.; Hosokawa, M.; Sashima, T.; Maoka, T.; Miyashita, K. Suppressive effects of alloxanthin and diatoxanthin from Halocynthia roretzi on LPS-induced expression of pro-inflammatory genes in RAW264.7 cells. J. Oleo Sci., 2008, 57(3), 181-189.
160. Heo, S.J.; Ko, S.C.; Kang, S.M.; Kang, H.S.; Kim, J.P.; Kim, S.H.; Jeon, Y.J. Cytoprotective effect of fucoxanthin isolated from brown algae Sargassum siliquastrum against H2O2-induced cell damage. Eur. Food Res. Technol., 2008, 228(1), 145-151.
161. Heo, S.J.; Yoon, W.J.; Kim, K.N.; Ahn, G.N.; Kang, S.M.; Kang, D.H.; Jeon, Y.J. Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food Chem. Toxicol., 2010, 48(8), 2045-2051.
162. Choi, S.K.; Park, Y.S.; Choi, D.K.; Chang, H.I. Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J. Microbiol. Biotechnol., 2008, 18(12), 1990-1996.
163. Sakai, S.; Sugawara, T.; Matsubara, K.; Hirata, T. Inhibitory effect of carotenoids on the degranulation of mast cells via suppression of antigen-induced aggregation of high affinity IgE receptors. J. Biol. Chem., 2009, 284(41), 28172-28179.
164. Sakai, S.; Sugawara, T.; Hirata, T. Inhibitory effect of dietary carotenoids on dinitrofluorobenzene-induced contact hypersensitivity in mice. Biosci. Biotechnol. Biochem., 2011, 75(5), 1013-1015.
165. González, S.; Astner, S.; An, W.; Goukassian, D.; Pathak, M.A. Dietary lutein/zeaxanthin decreases ultraviolet B-induced epidermal hyperproliferation and acute inflammation in hairless mice. J. Invest. Dermatol., 2003, 121(2), 399-405.
166. Riccioni, G.; Bucciarelli, T.; D’Orazio, N.; Palumbo, N.; Di Ilio, E.; Corradi, F.; Bazzano, L.A. Plasma antioxidants and asymptomatic carotid atherosclerotic disease. Ann. Nutr. Metab., 2008, 53(2), 86-90.
167. Gammone, M.A.; Riccioni, G.; D'Orazio, N. Carotenoids: Potential allies of cardiovascular health? Food Nutr. Res., 2015, 59, 26762.
168. de Jesus Raposo, M.F.; de Morais, A.M.M.B. Microalgae for the prevention of cardiovascular disease and stroke. Life Sci., 2015, 125, 32-41.
169. Iwamoto, T.; Hosoda, K.; Hirano, R.; Kurata, H.; Matsumoto, A.; Miki, W.; Kondo, K. Inhibition of low-density lipoprotein oxidation by astaxanthin. J. Atheroscler. Thromb., 2000, 7(4), 216-222.
170. Murillo, E. Hypercholesterolemic effect of canthaxanthin and astaxanthin in rats. Arch. Latinoamer. Nutr., 1992, 42(4), 409-413.
171. Augusti, P.R.; Conterato, G.M.; Somacal, S.; Sobieski, R.; Quatrin, A.; Maurer, L.; Rocha, M.P.; Denardin, I.T.; Emanuelli, T. Astaxanthin reduces oxidative stress, but not aortic damage in atherosclerotic rabbits. J. Cardiovasc. Pharmacol. Ther., 2009, 14(4), 314-322.
172. Yoshida, H.; Yanai, H.; Ito, K.; Tomono, Y.; Koikeda, T.; Tsukahara, H.; Tada, N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis, 2010, 209(2), 520-523.
173. Jialal, I.; Norkus, E.P.; Cristol, L.; Grundy, S.M. β-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta, 1991, 1086(1), 134-138.
174. Shaish, A.; Harari, A.; Hananshvili, L.; Cohen, H.; Bitzur, R.; Luvish, T.; Ulman, E.; Golan, M.; Ben-Amotz, A.; Gavish, D.; Rotstein, Z.; Harats, D. 9-cis β-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibratetreated patients. Atherosclerosis, 2006, 189(1), 215-221.
175. Harari, A.; Harats, D.; Marko, D.; Cohen, H.; Barshack, I.; Kamari, Y.; Shaish, A. A 9-cis β-carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice. J. Nutr., 2008, 138(10), 1923-1930.
176. El-Baky, A.; El Baz F.K.; El-Baroty, G.S. Production of carotenoids from marine microalgae and its evaluation as safe food colorant and lowering cholesterol agents. Am.-Euras. J. Agric. Environ. Sci., 2007, 2, 792-800.
177. Chidambara-Murthy, K.N.; Vanitha, A.; Rajesha, J.; Mahadeva-Swamy, M.; Sowmya, P.R.; Ravishankar, G.A. In vivo antioxidant activity of carotenoids from Dunaliella salina -a green microalga. Life Sci., 2005, 76, 1381-1390.
178. Nakaya, N.; Homma, Y.; Goto, Y. Cholesterol lowering effect of Spirulina. Nutr. Rep. Int., 1988, 37, 1329-1337.
179. Ramamoorthy, A.; Premakumari, S. Effect of supplementation of Spirulina on hypercholesterolemic patients. J. Food Sci. Technol., 1996, 33(2), 124-128.
180. Fong, B.; Cheung, M.; Lee, M. Effect of dietary Spirulina on plasma cholesterol and triglyceride levels in mice. 4th Asia-Pacific Conference on Algal Biotechnology, 2000, p. 150.
181. Fuhrman, B.; Elis, A.; Aviram, M. Hypocholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem. Biophys. Res. Commun., 1997, 233(3), 658-662.
182. Holvoet, P.; Collen, D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J., 1994, 8(15), 1279-1284.
183. Frei, B. Cardiovascular disease and nutrient antioxidants: Role of low_density lipoprotein oxidation. Crit. Rev. Food Sci. Nutr., 1995, 35(1-2), 83-98.
184. Kaliora, A.C.; Dedoussis, G.V.Z.; Schmidt, H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis, 2006, 187(1), 1-17.
185. Abidov, M.; Ramazanov, Z.; Seifulla, R.; Grachev, S. The effects of Xanthigen™ in the weight management of obese premenopausal women with non_alcoholic fatty liver disease and normal liver fat. Diabetes Obes. Metab., 2010, 12(1), 72-81.
186. D’Orazio, N.; Gammone, M.A.; Gemello, E.; De Girolamo, M.; Cusenza, S.; Riccioni, G. Marine bioactives: Pharmacological properties and potential applications against inflammatory diseases. Mar. Drugs, 2012, 10(4), 812-833.
187. D’Orazio, N.; Gemello, E.; Gammone, M.A.; de Girolamo, M.; Ficoneri, C.; Riccioni, G. Fucoxanthin: A treasure from the sea. Mar. Drugs, 2012, 10(3), 604-616.
188. Gammone, M.A.; Gemello, E.; Riccioni, G.; D'Orazio, N. Marine bioactives and potential application in sports. Mar. Drugs, 2014, 12(5), 2357-2382.
189. Arnal, E.; Miranda, M.; Barcia, J.; Bosch-Morell, F.; Romero, F.J. Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. Neuroscience, 2010, 166(1), 271-278.
190. Kim, J.E.; Leite, J.O.; Smyth, J.A.; Clark, R.M.; Fernandez, M.L. A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs. J. Nutr., 2011, 141(8), 1458-1463.
191. Kritchevsky, S.B.; Bush, A.J.; Pahor, M.; Gross, M.D. Serum carotenoids and markers of inflammation in nonsmokers. Amer. J. Epidemiol., 2000, 152(11), 1065-1071.
192. Aizawa, T.; Wei, H.; Miano, J.M.; Abe, J.I.; Berk, B.C.; Yan, C. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ. Res., 2003, 93(5), 406-413.
193. Monroy-Ruiz, J.; Sevilla, M.Á.; Carrón, R.; Montero, M.J. Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats. Pharmacol. Res., 2011, 63(1), 44-50.
194. Preuss, H.G.; Echard, B.; Yamashita, E.; Perricone, N.V. High dose astaxanthin lowers blood pressure and increases insulin sensitivity in rats: Are these effects interdependent? Int. J. Med. Sci., 2011, 8(2), 126-138.
195. Hussein, G.; Nakamura, M.; Zhao, Q.; Iguchi, T.; Goto, H.; Sankawa, U.; Watanabe, H. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol. Pharmaceut. Bull., 2005, 28(1), 47-52.
196. Sasaki, Y.; Kobara, N.; Higashino, S.; Giddings, J.C.; Yamamoto, J. Astaxanthin inhibits thrombosis in cerebral vessels of strokeprone spontaneously hypertensive rats. Nutr. Res., 2011, 31(10), 784-789.
197. Hu, M.Y.; Li, Y.L.; Jiang, C.H.; Liu, Z.Q.; Qu, S.L.; Huang, Y.M. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits. Nutrition, 2008, 24(10), 1030-1038.
198. Martin, K.R.; Wu, D.; Meydani, M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis, 2000, 150(2), 265-274.
199. Hozawa, A.; Jacobs D.R. Jr.; Steffes, M.W.; Gross, M.D.; Steffen, L.M.; Lee, D.H. Circulating carotenoid concentrations and incident hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) study. J. Hypertension, 2009, 27(2), 237.
200. Cai, X.; Li, X.; Li, L.; Huang, X.Z.; Liu, Y.S.; Chen, L.; Zhang, M. Adiponectin reduces carotid atherosclerotic plaque formation in ApoE-/-mice: Roles of oxidative and nitrosative stress and inducible nitric oxide synthase. Mol. Med. Rep., 2015, 11(3), 1715-1721.
201. Kim, O.Y.; Koh, S.J.; Jang, Y.; Chae, J.S.; Kim, J.Y.; Kim, H.J.; Lee, J.H. Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis. Clin. Chim. Acta, 2006, 370(1), 63-71.
202. Li, W.; Hellsten, A.; Jacobsson, L.S.; Blomqvist, H.M.; Olsson, A.G.; Yuan, X.M. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J. Mol. Cell. Cardiol., 2004, 37(5), 969-978.
203. Uchiyama, A.; Okada, Y. Clinical efficacy of astaxanthincontaining Haematococcus pluvialis extract for the volunteers at risk of metabolic syndrome. J. Clin. Biochem. Nutr., 2008, 43, 38-43.
204. Kishimoto, Y.; Tani, M.; Uto-Kondo, H.; Iizuka, M.; Saita, E.; Sone, H.; Kondo, K. Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages. Eur. J. Nutr., 2010, 49(2), 119-126.
205. Klipstein-Grobusch, K.; Launer, L.; Geleijnse, J.M.; Boeing, H.; Hofman, A.; Witteman, J.C.M. Serum carotenoids and atherosclerosis: The Rotterdam study. Atherosclerosis, 2000, 148(1), 49-56.
206. Riccioni, G.; D'Orazio, N.; Palumbo, N.; Bucciarelli, V.; di Ilio, E.; Bazzano, L.A.; Bucciarelli, T. Relationship between plasma antioxidant concentrations and carotid intima-media thickness: The Asymptomatic carotid atherosclerotic disease in manfredonia study. Eur. J. Cardiovasc. Prev. Rehab., 2009, 16(3), 351-357.
207. Vílchez, C.; Forján, E.; Cuaresma, M.; Bédmar, F.; Garbayo, I.; Vega, J.M. Marine carotenoids: Biological functions and commercial applications. Mar. Drugs, 2011, 9(3), 319-333.
208. Pool-Zobel, B.L.; Bub, A.; Müller, H.; Wollowski, I.; Rechkemmer, G. Consumption of vegetables reduces genetic damage in humans: First results of a human intervention trial with carotenoid-rich foods. Carcinogenesis, 1997, 18(9), 1847-1850.
209. Agarwal, S.; Rao, A.V. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study. Lipids, 1998, 33(10), 981-984.
210. Rao, A.V.; Agarwal, S. Effect of diet and smoking on serum lycopene and lipid peroxidation. Nutr. Res., 1998, 18(4), 713-721.
211. Rissanen, T.; Voutilainen, S.; Nyyssönen, K.; Salonen, R.; Salonen, J.T. Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid artery wall. Arterioscl. Throm. Vas., 2000, 20(12), 2677-2681.
212. Dwyer, J.H.; Navab, M.; Dwyer, K.M.; Hassan, K.; Sun, P.; Shircore, A.; Fogelman, A.M. Oxygenated carotenoid lutein and progression of early atherosclerosis: The Los Angeles Atherosclerosis study. Circulation, 2001, 103(24), 2922-2927.
213. Dwyer, J.H.; Paul-Labrador, M.J.; Fan, J.; Shircore, A.M.; Merz, C.N.B.; Dwyer, K.M. Progression of carotid intima-media thickness and plasma antioxidants: The Los Angeles atherosclerosis study. Arterioscl. Throm. Vas., 2004, 24(2), 313-319.
214. Rissanen, T.; Voutilainen, S.; Nyyssönen, K.; Salonen, J.T. Lycopene, atherosclerosis, and coronary heart disease. Exp. Biol. Med., 2002, 227(10), 900-907.
215. Ascherio, A.; Rimm, E.B.; Hernán, M.A.; Giovannucci, E.; Kawachi, I.; Stampfer, M.J.; Willett, W.C. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann. Intern. Med., 1999, 130(12), 963-970.
216. Ikeda, K.; Kitamura, A.; Machida, H.; Watanabe, M.; Negishi, H.; Hiraoka, J.; Nakano, T. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke_prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol., 2003, 30(1-2), 44-48.
217. Handelman, G.J.; Packer, L.; Cross, C.E. Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. Am. J. Clin. Nutr., 1996, 63(4), 559-565.
218. Street, D.A.; Comstock, G.W.; Salkeld, R.M.; Schüep, W.; Klag, M.J. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation, 1994, 90(3), 1154-1161.
219. Kohlmeier, L.; Kark, J.D.; Gomez-Gracia, E.; Martin, B.C.; Steck, S.E.; Kardinaal, A.F.; Kok, F.J. Lycopene and myocardial infarction risk in the EURAMIC study. Am. J. Epidemiol., 1997, 146(8), 618-626.
220. Koh, W.P.; Yuan, J.M.; Wang, R.; Lee, Y.P.; Lee, B.L.; Yu, M.C.; Ong, C.N. Plasma carotenoids and risk of acute myocardial infarction in the Singapore Chinese Health Study. Nutr. Metab. Cardiovasc. Dis., 2011, 21(9), 685-690.
221. Kristenson, M.; Ziedén, B.; Kucinskienë, Z.; Elinder, L.S.; Bergdahl, B.; Elwing, B.; Abaravicius, A.; Razinkovienë, L.; Calkauskas, H.; Olsson, A.G. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross sectional study of men aged 50. Br. Med. J., 1997, 314(7081), 629-633.
222. Osganian, S.K.; Stampfer, M.J.; Rimm, E.; Spiegelman, D.; Manson, J.E.; Willett, W.C. Dietary carotenoids and risk of coronary artery disease in women. Am. J. Clin. Nutr., 2003, 77(6), 1390-1399.
223. Sesso, H.D.; Liu, S.; Gaziano, J.M.; Buring, J.E. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J. Nutr., 2003, 133(7), 2336-2341.
224. Sesso, H.D.; Buring, J.E.; Norkus, E.P.; Gaziano, J.M. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men. Am. J. Clin. Nutr., 2005, 81(5), 990-997.
225. Voutilainen, S.; Nurmi, T.; Mursu, J.; Rissanen, T.H. Carotenoids and cardiovascular health. Am. J. Clin. Nutr., 2006, 83(6), 1265-1271.
226. Ito, Y.; Kurata, M.; Suzuki, K.; Hamajima, N.; Hishida, H.; Aoki, K. Cardiovascular disease mortality and serum carotenoid levels: A Japanese population-based follow-up study. J. Epidemiol., 2006, 16(4), 154-160.
227. Lidebjer, C.; Leanderson, P.; Ernerudh, J.; Jonasson, L. Low plasma levels of oxygenated carotenoids in patients with coronary artery disease. Nutr. Metab. Cardiovasc. Dis., 2007, 17(6), 448-456.
228. Riccioni, G.; D’Orazio, N.; Franceschelli, S.; Speranza, L. Marine carotenoids and cardiovascular risk markers. Mar. Drugs, 2011, 9(7), 1166-1175.
229. Nakao, R.; Nelson, O.L.; Park, J.S.; Mathison, B.D.; Thompson, P.A.; Chew, B.P. Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. Anticancer Res., 2010, 30(7), 2721-2725.
230. Kritchevsky, S.B. β-carotene, carotenoids and the prevention of coronary heart disease. J. Nutr., 1999, 129(1), 5-8.
231. Ford, E.S.; Giles, W.H. Serum vitamins, carotenoids, and angina pectoris: Findings from the National Health and Nutrition Examination Survey III. Ann. Epidemiol., 2000, 10(2), 106-116.
232. Christensen, W.G.; Gaziano, J.M.; Hennekens, C.H. Design of Physicians' Health Study II-a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann. Epidemiol., 2000, 10(2), 125-134.
233. Zinov’eva, V.N.; Spasov, A.A. Mechanisms of the anticancer effects of plant polyphenols. II. Suppression of tumor growth. Biochemistry -Moscow, 2011, 5(3), 231-240.
234. Hosokawa, M.; Wanezaki, S.; Miyauchi, K.; Kurihara, H.; Kohno, H.; Kawabata, J.; Odashima, S.; Takahashi, K. Apoptosis-inducing effect of fucoxanthin on human leukemia cell line HL-60. Food Sci. Technol. Res., 1999, 5(3), 243-246.
235. Hosokawa, M.; Kudo, M.; Maeda, H.; Kohno, H.; Tanaka, T.; Miyashita, K. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARγ ligand, troglitazone, on colon cancer cells. Biochim. Biophys. Acta, 2004, 1675(1), 113-119.
236. Kotake-Nara, E.; Terasaki, M.; Nagao, A. Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells. Biosci. Biotechnol. Biochem., 2005, 69(1), 224-227.
237. Kotake-Nara, E.; Asai, A.; Nagao, A. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Cancer Lett., 2005, 220(1), 75-84.
238. Das, S.K.; Hashimoto, T.; Shimizu, K.; Yoshida, T.; Sakai, T.; Sowa, Y.; Komoto, A.; Kanazawa, K. Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Biochim. Biophys. Acta, 2005, 1726(3), 328-335.
239. Das, S.K.; Hashimoto, T.; Kanazawa, K. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochim. Biophys. Acta, 2008, 1780(4), 743-749.
240. Moreau, D.; Tomasoni, C.; Jacquot, C.; Kaas, R.; Le Guedes, R.; Cadoret, J.P.; Muller-Feuga, A.; Kontiza, I.; Vagias, C.; Roussis, V.; Roussakis, C. Cultivated microalgae and the carotenoid fucoxanthin from Odontella aurita as potent anti-proliferative agents in bronchopulmonary and epithelial cell lines. Environ. Toxicol. Pharmacol., 2006, 22(1), 97-103.
241. Cui, Y.; Lu, Z.; Bai, L.; Shi, Z.; Zhao, W.E.; Zhao, B. β-carotene induces apoptosis and up-regulates peroxisome proliferatoractivated receptor γ expression and reactive oxygen species production in MCF-7 cancer cells. Eur. J. Cancer, 2007, 43(17), 2590-2601.
242. Bertram, J.S. Carotenoids and gene regulation. Nutr. Rev., 1999, 57(6), 182-191.
243. Guerin, M.; Huntley, M.E.; Olaizola, M. Haematococcus astaxanthin: Applications for human health and nutrition. Trends Biotechnol., 2003, 21(5), 210-216.
244. Bertram, J.S.; Bortkiewicz, H. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am. J. Clin. Nutr., 1995, 62(6), 1327S-1336S.
245. Stahl, W.; Nicolai, S.; Briviba, K.; Hanusch, M.; Broszeit, G.; Peters, M.; Sies, H. Biological activities of natural and synthetic carotenoids: Induction of gap junctional communication and singlet oxygen quenching. Carcinogenesis, 1997, 18(1), 89-92.
246. Daubrawa, F.; Sies, H.; Stahl, W. Astaxanthin diminishes gap junctional intercellular communication in primary human fibroblasts. J. Nutr., 2005, 135(11), 2507-2511.
247. Hix, L.M.; Lockwood, S.F.; Bertram, J.S. Upregulation of connexin 43 protein expression and increased gap junctional communication by water soluble disodium disuccinate astaxanthin derivatives. Cancer Lett., 2004, 211(1), 25-37.
248. Jyonouchi, H.; Sun, S.; Iijima, K.; Gross, M.D. Antitumor activity of astaxanthin and its mode of action. Nutr. Cancer, 2000, 36(1), 59-65.
249. Okuzumi, J.; Nishino, H.; Murakoshi, M.; Iwashima, A.; Tanaka, Y.; Yamane, T.; Takahashi, T. Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Lett., 1990, 55(1), 75-81.
250. Cerveny, C.G.; Chew, B.P.; Park, J.S.; Wong, T.S. Dietary lutein inhibits tumor growth and normalizes lymphocyte subsets in tumorbearing mice. FASEB J., 1999, 13(4), A210.
251. Chew, B.P.; Brown, C.M.; Park, J.S.; Mixter, P.F. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Anticancer Res., 2003, 23(4), 3333-3339.
252. Sumantran, V.N.; Zhang, R.; Lee, D.S.; Wicha, M.S. Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidem. Biomar., 2000, 9(3), 257-263.
253. Chew, B.P.; Park, J.S. Carotenoid action on the immune response. J. Nutr., 2004, 134(1), 257S-261S.
254. Chew, B.P.; Park, J.S.; Wong, M.W.; Wong, T.S. A comparison of the anticancer activities of dietary β-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res., 1999, 19(3A), 1849-1853.
255. Gyémánt, N.; Tanaka, M.; Molnár, P.; Deli, J.; Mándoky, L.; Molnár, J. Reversal of multidrug resistance of cancer cells in vitro: Modification of drug resistance by selected carotenoids. Anticancer Res., 2006, 26(1A), 367-374.
256. Pasquet, V.; Morisset, P.; Lhammouine, S.; Chepied, A.; Aumailley, L.; Berard, J.B.; Picot, L. Antiproliferative activity of violaxanthin isolated from bioguided fractionation of Dunaliella tertiolecta extracts. Mar. Drugs, 2011, 9(5), 819-831.
257. Hashimoto, T.; Ozaki, Y.; Taminato, M.; Das, S.K.; Mizuno, M.; Yoshimura, K.; Kanazawa, K. The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. Br. J. Nutr., 2009, 102(02), 242-248.
258. Rwigemera, A.; Mamelona, J.; Martin, L.J. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231. Anticancer Res., 2015, 35(1), 207-219.
259. Jewell, C.; O'Brien, N.M. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br. J. Nutr., 1999, 81(3), 235-242.
260. Tanumihardjo, S.A.; Yang, Z. In: Encyclopedia of Human Nutrition. 2nd ed.; Caballero, B.; Allen, L.; Prentice, A., Eds.; Elsevier Ltd: Oxford, 2005, pp. 339-345.
261. Baudelet, P.H.; Gagez, A.L.; Bérard, J.B.; Juin, C.; Bridiau, N.; Kaas, R.; Picot, L. Antiproliferative activity of Cyanophora paradoxa pigments in melanoma, breast and lung cancer cells. Mar. Drugs, 2013, 11(11), 4390-4406.
262. Liu, Y.Z.; Yang, C.M.; Chen, J.Y.; Liao, J.W.; Hu, M.L. α-carotene inhibits metastasis in Lewis lung carcinoma in vitro, and suppresses lung metastasis and tumor growth in combination with taxol in tumor xenografted C57BL/6 mice. J. Nutr. Biochem., 2015, 26(6), 607-615.
263. Murakoshi, M.; Nishino, H.; Satomi, Y.; Takayasu, J.; Hasegawa, T.; Tokuda, H.; Iwasaki, R. Potent preventive action of α-carotene against carcinogenesis: Spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by α-carotene than by β-carotene. Cancer Res., 1992, 52(23), 6583-6587.
264. Bertram, J.S. Induction of connexin 43 by carotenoids: Functional consequences. Arch. Biochem. Biophys., 2004, 430(1), 120-126.
265. Bertram, J.S.; Vine, A.L. Cancer prevention by retinoids and carotenoids: Independent action on a common target. Biochim. Biophys. Acta, 2005, 1740(2), 170-178.
266. Mayne, S.T.; Handelman, G.J.; Beecher, G. β-carotene and lung cancer promotion in heavy smokers -a plausible relationship? J. Nat. Cancer Inst., 1996, 88(21), 1513-1515.
267. Senesse, P.; Touvier, M.; Kesse, E.; Faivre, J.; Boutron-Ruault, M.C. Tobacco use and associations of β-carotene and vitamin intakes with colorectal adenoma risk. J. Nutr., 2005, 135(10), 2468-2472.
268. Kim, K.N.; Heo, S.J.; Kang, S.M.; Ahn, G.; Jeon, Y.J. Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROSmediated Bcl-xL pathway. Toxicol. In Vitro, 2010, 24(6), 1648-1654.
269. Konishi, I.; Hosokawa, M.; Sashima, T.; Kobayashi, H.; Miyashita, K. Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Comp. Biochem. Physiol. Part C: Toxicol. Pharmacol., 2006, 142(1), 53-59.
270. Sugawara, T.; Baskaran, V.; Tsuzuki, W.; Nagao, A. Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. J. Nutr., 2002, 132(5), 946-951.
271. Ishikawa, C.; Tafuku, S.; Kadekaru, T.; Sawada, S.; Tomita, M.; Okudaira, T.; Mori, N. Antiadult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int. J. Cancer, 2008, 123(11), 2702-2712.
272. Ganesan, P.; Noda, K.; Manabe, Y.; Ohkubo, T.; Tanaka, Y.; Maoka, T.; Hirata, T. Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (HL-60) cells. Biochim. Biophys. Acta, 2011, 1810(5), 497-503.
273. Yamamoto, K.; Ishikawa, C.; Katano, H.; Yasumoto, T.; Mori, N. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas. Cancer Lett., 2011, 300(2), 225-234.
274. Tanaka, T.; Morishita, Y.; Suzui, M.; Kojima, T.; Okumura, A.; Mori, H. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis, 1994, 15(1), 15-19.
275. Anderson, M. Method of inhibiting 5-a reductase with astaxanthin to prevent and treat benign prostate hyperplasia (BPH) and prostate cancer in human males. U.S. patent 6,277,417, August 21, 2001.
276. Asai, A.; Sugawara, T.; Ono, H.; Nagao, A. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: Formation and cytotoxicity of fucoxanthin metabolites. Drug Metab. Dispos., 2004, 32(2), 205-211.
277. Rafi, M.M.; Kanakasabai, S.; Gokarn, S.V.; Krueger, E.G.; Bright, J.J. Dietary lutein modulates growth and survival genes in prostate cancer cells. J. Med. Food, 2015, 18(2), 173-181.
278. Kotake-Nara, E.; Kushiro, M.; Zhang, H.; Sugawara, T.; Miyashita, K.; Nagao, A. Carotenoids affect proliferation of human prostate cancer cells. J. Nutr., 2001, 131(12), 3303-3306.
279. Zhang, Z.; Zhang, P.; Hamada, M.; Takahashi, S.; Xing, G.; Liu, J.; Sugiura, N. Potential chemoprevention effect of dietary fucoxanthin on urinary bladder cancer EJ-1 cell line. Oncol. Rep., 2008, 20(5), 1099-1103.
280. Yoshiko, S.; Hoyoku, N. Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. In Vivo, 2007, 21(2), 305-309.
281. Satomi, Y.; Nishino, H. Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim. Biophys. Acta, 2009, 1790(4), 260-266.
282. Graydon, R.; Gilchrist, S.E.; Young, I.S.; Obermüller-Jevic, U.; Hasselwander, O.; Woodside, J.V. Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial. Eur. J. Clin. Nutr., 2007, 61(10), 1196-1200.
283. Schwarz, S.; Obermüller-Jevic, U.C.; Hellmis, E.; Koch, W.; Jacobi, G.; Biesalski, H.K. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr., 2008, 138(1), 49-53.
284. Giovannucci, E.; Ascherio, A.; Rimm, E.B.; Stampfer, M.J.; Colditz, G.A.; Willett, W.C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst., 1995, 87(23), 1767-1776.
285. Wang, Y.; Cui, R.; Xiao, Y.; Fang, J.; Xu, Q. Effect of carotene and lycopene on the risk of prostate cancer: A systematic review and dose-response meta-analysis of observational studies. PLoS ONE, 2015, 10(9), e0137427.
286. Enger, S.M.; Longnecker, M.P.; Chen, M.J.; Harper, J.M.; Lee, E.R.; Frankl, H.D.; Haile, R.W. Dietary intake of specific carotenoids and vitamins A, C, and E, and prevalence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 1996, 5(3), 147-153.
287. Mori, H.; Tanaka, T.; Sugie, S.; Yoshimi, N.; Kawamori, T.; Hirose, Y.; Ohnishi, M. Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis. J. Cell Biochem. Suppl., 1997, 27, 35-41.
288. Tanaka, T.; Kawamori, T.; Ohnishi, M.; Makita, H.; Mori, H.; Satoh, K.; Hara, A. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis, 1995, 16(12), 2957-2963.
289. Palozza, P.; Torelli, C.; Boninsegna, A.; Simone, R.; Catalano, A.; Mele, M.C.; Picci, N. Growth-inhibitory effects of the astaxanthinrich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett., 2009, 283(1), 108-117.
290. Cha, K.H.; Koo, S.Y.; Lee, D.U. Antiproliferative effects of carotenoids extracted from Chlorella ellipsoidea and Chlorella vulgaris on human colon cancer cells. J. Agric. Food Chem., 2008, 56(22), 10521-10526.
291. Kawee-Ai, A.; Kim, S.M. Application of microalgal fucoxanthin for the reduction of colon cancer risk: Inhibitory activity of fucoxanthin against beta-glucuronidase and DLD-1 cancer cells. Nat. Prod. Commun., 2014, 9(7), 921-924.
292. Kim, J.M.; Araki, S.; Kim, D.J.; Park, C.B.; Takasuka, N.; Baba-Toriyama, H.; Ota, T.; Nir, Z.; Khachik, F.; Shimidzu, N.; Tanaka, Y.; Osawa, T.; Uraji, T.; Murakoshi, M.; Nishino, H.; Tsuda, H. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis, 1998, 19(1), 81-85.
293. Narisawa, T.; Fukaura, Y.; Hasebe, M.; Ito, M.; Aizawa, R.; Murakoshi, M.; Uemura, S.; Khachik, F.; Nishino, H. Inhibitory effects of natural carotenoids, α-carotene, β-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett., 1996, 107(1), 137-142.
294. Khare, S.; Chaudhary, K.; Bissonnette, M.; Carroll, R. Aberrant crypt foci in colon cancer epidemiology. Meth. Mol. Biol., 2009, 472, 373-386.
295. Erhardt, J.G.; Meisner, C.; Bode, J.C.; Bode, C. Lycopene, β-carotene, and colorectal adenomas. Am. J. Clin. Nutr., 2003, 78(6), 1219-1224.
296. Huang, R.F.; Wei, Y.J.; Inbaraj, B.S.; Chen, B.H. Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene. Int. J. Nanomed., 2015, 10, 2823-2846.
297. San Millán, C.; Soldevilla, B.; Martín, P.; Gil-Calderón, B.; Compte, M.; Pérez-Sacristán, B.; Donoso, E.; Peña, C.; Romero, J.; Granado-Lorencio, F.; Bonilla, F.; Domínguez, G. β-cryptoxanthin synergistically enhances the antitumoral activity of oxaliplatin through ΔNP73 negative regulation in colon cancer. Clin. Cancer Res., 2015, 21(19), 4398-4409.
298. Ugocsai, K.; Varga, A.; Molnár, P.; Antus, S.; Molnár, J. Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP. In Vivo, 2005, 19(2), 433-438.
299. Gradelet, S.; Le Bon, A.M.; Bergès, R.; Suschetet, M.; Astorg, P. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: Role of the modulation of aflatoxin B1 metabolism. Carcinogenesis, 1998, 19(3), 403-411.
300. Astorg, P.; Gradelet, S.; Bergès, R.; Suschetet, M. Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr. Cancer, 1997, 29(1), 60-68.
301. Yang, C.M.; Huang, S.M.; Liu, C.L.; Hu M.L. Apo-8'-lycopenal induces expression of HO-1 and NQO-1 via the ERK/p38-Nrf2-ARE pathway in human HepG2 cells. J. Agric. Food Chem., 2012, 60(6), 1576-1585.
302. Song, X.; Wang, M.; Zhang, L.; Zhang, J.; Wang, X.; Liu, W.; Gu, X.; Lv, C. Changes in cell ultrastructure and inhibition of JAK1/STAT3 signaling pathway in CBRH-7919 cells with astaxanthin. Toxicol. Mech. Methods, 2012, 22(9), 679-686.
303. Liu, C.L.; Huang, Y.S.; Hosokawa, M.; Miyashita, K.; Hu, M.L. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication. Chem. Biol. Interact., 2009, 182(2-3), 165-172.
304. Liu, C.L.; Lim, Y.P.; Hu, M.L. Fucoxanthin enhances cisplatininduced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells. Mar. Drugs, 2013, 11(1), 50-66.
305. Lee, B.J.; Park, J.-J.; Jung, S.J.; Hong, S.G.; Joo, M.K.; Kim, J.H.; Yeon, J.E.; Kim, J.S.; Chun, H.J.; Lee, H.S.; Byun, K.S.; Lee, S.W.; Bak, Y.-T. Anticancer effects of astaxanthin in stomach cancer cell lines. Gastroenterology, 2009, 136(5), A-319.
306. Yu, R.X.; Hu, X.M.; Xu, S.Q.; Jiang, Z.J.; Yang, W. Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway. Eur. J. Pharmacol., 2011, 657(1-3), 10-19.
307. Park, Y.; Choi, J.; Lim, J.W.; Kim, H. β-carotene-induced apoptosis is mediated with loss of Ku proteins in gastric cancer AGS cells. Genes Nutr., 2015, 10(4), 467.
308. Kim, M.J.; Kim, H. Anticancer effect of lycopene in gastric carcinogenesis. J. Cancer Prev., 2015, 20(2), 92-96.
309. Liu, B.H.; Lee, Y.K. Effect of total secondary carotenoids extracts from Chlorococcum sp. on Helicobacter pylori-infected BALB/c mice. Int. Immunopharmacol., 2003, 3(7), 979-986.
310. Amaro, H.M.; Barros, R.; Guedes, A.C.; Sousa-Pinto, I.; Malcata, F.X. Microalgal compounds modulate carcinogenesis in the gastrointestinal tract. Trends Biotechnol., 2013, 31(2), 92-98.
311. Bennedsen, M.; Wang, X.; Willén, R.; Wadström, T.; Andersen, L.P. Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett., 2000, 70(3), 185-189.
312. Garewal, H.S.; Schantz, S. Emerging role of β-carotene and antioxidant nutrients in prevention of oral cancer. Arch. Otolaryngol. Head. Neck. Surg., 1995, 121(2), 141-144.
313. Garewal, H. Antioxidants in oral cancer prevention. Am. J. Clin. Nutr., 1995, 62(Suppl 6), 1410S-1416S.
314. Nagao, T.; Warnakulasuriya, S.; Nakamura, T.; Kato, S.; Yamamoto, K.; Fukano, H.; Suzuki, K.; Shimozato, K.; Hashimoto, S. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: A randomized controlled trial. Int. J. Cancer, 2015, 136(7), 1708-1717.
315. Kurihara, H.; Koda, H.; Asami, S.; Kiso, Y.; Tanaka, T. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci., 2002, 70(21), 2509-2520.
316. Kozuki, Y.; Miura, Y.; Yagasaki, K. Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett., 2000, 151(1), 111-115.
317. Tripathi, D.N.; Jena, G.B. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: Role of Nrf2, p53, p38 and phase-II enzymes. Mutat. Res., 2010, 696(1), 69-80.
318. Kang, J.O.; Kim, S.J.; Kim, H. Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CCl4-treated rats. Methods Find. Exp. Clin. Pharmacol., 2001, 23(2), 79-84.
319. Ohno, T.; Shimizu, M.; Shirakami, Y.; Miyazaki, T.; Ideta, T.; Kochi, T.; Kubota, M.; Sakai, H.; Tanaka, T.; Moriwaki, H. Preventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57/BL/KsJ-db/db obese mice. Hepatol. Res., 2016, 46(3), E201-E209.
320. Prabhu, P.N.; Ashokkumar, P.; Sudhandiran, G. Antioxidative and antiproliferative effects of astaxanthin during the initiation stages of 1,2-dimethyl hydrazine-induced experimental colon carcinogenesis. Fundam. Clin. Pharm., 2009, 23(2), 225-234.
321. Vine, A.L.; Bertram, J.S. Upregulation of connexin 43 by retinoids but not by non-provitamin A carotenoids requires RARs. Nutr. Cancer, 2005, 52(1), 105-113.
322. Krishnaraj, R.N.; Kumari, S.S.; Mukhopadhyay, S.S. Antagonistic molecular interactions of photosynthetic pigments with molecular disease targets: A new approach to treat AD and ALS. J. Recept. Signal Transduct., 2016, 36(1), 67-71.
323. Prema, A.; Janakiraman, U.; Manivasagam, T.; Arokiasamy, J.T. Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice. Neurosci. Lett., 2015, 599, 12-19.
324. Ikeda, Y.; Tsuji, S.; Satoh, A.; Ishikura, M.; Shirasawa, T.; Shimizu, T. Protective effects of astaxanthin on 6-hydroxydopamineinduced apoptosis in human neuroblastoma SH-SY5Y cells. J. Neurochem., 2008, 107(6), 1730-1740.
325. Shen, H.; Kuo, C.C.; Chou, J.; Delvolve, A.; Jackson, S.N.; Post, J.; Harvey, B.K. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J., 2009, 23(6), 1958-1968.
326. Dufossé, L.; Galaup, P.; Yaron, A.; Arad, S.M.; Blanc, P.; Murthy, K.N.C.; Ravishankar, G.A. Microorganisms and microalgae as sources of pigments for food use: A scientific oddity or an industrial reality? Trends Food Sci. Technol., 2005, 16(9), 389-406.
327. Kidd, P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern. Med. Rev., 2011, 16(4), 355-364.
328. Liu, X.; Shibata, T.; Hisaka, S.; Osawa, T. Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism. Brain Res., 2009, 1254, 18-27.
329. Choi, A.M.; Alam, J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol., 1996, 15(1), 9-19.
330. Lee, D.H.; Lee, Y.J.; Kwon, K.H. Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat. J. Clin. Biochem. Nutr., 2010, 47(2), 121-129.
331. Wang, H.Q.; Sun, X.B.; Xu, Y.X.; Zhao, H.; Zhu, Q.Y.; Zhu, C.Q. Astaxanthin upregulates heme oxygenase-1 expression through ERK1/2 pathway and its protective effect against beta-amyloidinduced cytotoxicity in SH-SY5Y cells. Brain Res., 2010, 1360, 159-167.
332. Chang, C.H.; Chen, C.Y.; Chiou, J.Y.; Peng, R.Y.; Peng, C.H. Astaxanthin secured apoptotic death of PC12 cells induced by β-amyloid peptide 25-35: Its molecular action targets. J. Med. Food, 2010, 13(3), 548-556.
333. Ye, Q.; Huang, B.; Zhang, X.; Zhu, Y.; Chen, X. Astaxanthin protects against MPP+-induced oxidative stress in PC12 cells via the HO-1/NOX2 axis. BMC Neurosci., 2012, 13(1), 156.
334. Chan, K.C.; Mong, M.C.; Yin, M.C. Antioxidative and antiinflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells. J. Food Sci., 2009, 74(7), H225-H231.
335. Wen, X.; Huang, A.; Hu, J.; Zhong, Z.; Liu, Y.; Li, Z.; Liu, Z. Neuroprotective effect of astaxanthin against glutamate-induced cytotoxicity in HT22 cells: Involvement of the Akt/GSK-3β pathway. Neuroscience, 2015, 303, 558-568.
336. Kim, J.H.; Choi, W.; Lee, J.H.; Jeon, S.J.; Choi, Y.H.; Kim, B.W.; Nam, S.W. Astaxanthin inhibits H2O2-mediated apoptotic cell death in mouse neural progenitor cells via modulation of P38 and MEK signaling pathways. J. Microbiol. Biotechnol., 2009, 19(11), 1355-1363.
337. 2-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Res., 2010, 1360, 40-48.
338. Lin, T.Y.; Lu, C.W.; Wang, S.J. Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca2+ entry and mitogen-activated protein kinase signaling pathway. J. Agric. Food Chem., 2010, 58(14), 8271-8278.
339. Kim, J.H.; Nam, S.W.; Kim, B.W.; Kim, W.J.; Choi, Y.H. Astaxanthin improves the proliferative capacity as well as the osteogenic and adipogenic differentiation potential in neural stem cells. Food Chem. Toxicol., 2010, 48(6), 1741-1745.
340. Bai, W.; Wang, X.; Wang, Z.; Wang, H.; Chen, J. The effect of astaxanthin (AST) on neurotrophin-3 (NT-3) expression in rats after compressive spinal cord injury (SCI). Afr. J. Pharm. Pharmacol., 2012, 6(34), 2559-2564.
341. Abadie-Guedes, R.; Santos, S.D.; Cahú, T.B.; Guedes, R.C.; De Souza Bezerra, R. Dose-dependent effects of astaxanthin on cortical spreading depression in chronically ethanol-treated adult rats. Alcohol. Clin. Exp. Res., 2008, 32(8), 1417-1421.
342. Abadie-Guedes, R.; Guedes, R.C.; Bezerra, R.S. The impairing effect of acute ethanol on spreading depression is antagonized by astaxanthin in rats of 2 young-adult ages. Alcohol. Clin. Exp. Res., 2012, 36(9), 1563-1567.
343. Nakashima, Y.; Ohsawa, I.; Konishi, F.; Hasegawa, T.; Kumamoto, S.; Suzuki, Y.; Ohta, S. Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice. Neurosci. Lett., 2009, 464(3), 193-198.
344. Min, J.Y.; Min, K.B. Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer's disease mortality in older adults. Dement. Geriatr. Cogn. Disord., 2014, 37, 246-256.
345. Takeda, A.; Nyssen, O.P.; Syed, A.; Jansen, E.; Bueno-de-Mesquita, B.; Gallo, V. Vitamin A and carotenoids and the risk of Parkinson's disease: A systematic review and meta-analysis. Neuroepidemiology, 2014, 42(1), 25-38.
346. Paolisso, G.; Giugliano, D. Oxidative stress and insulin action: Is there a relationship? Diabetologia, 1996, 39(3), 357-363.
347. Tyssandier, V.; Reboul, E.; Dumas, J.F.; Bouteloup-Demange, C.; Armand, M.; Marcand, J.; Borel, P. Processing of vegetable-borne carotenoids in the human stomach and duodenum. Am. J. Physiol. Gastroint. Liver Physiol., 2003, 284(6), G913-G923.
348. Ma, Q.Y.; Fang, M.; Zheng, J.H.; Ren, D.F.; Lu, J. Optimised extraction of β-carotene from Spirulina platensis and hypoglycaemic effect in streptozotocin-induced diabetic mice. J. Sci. Food Agric., 2016, 96(5), 1783-1789.
349. Harari, A.; Harats, D.; Marko, D.; Cohen, H.; Barshack, I.; Gonen, A.; Shaish, A. Supplementation with 9-cis-β-carotene-rich alga Dunaliella improves hyperglycemia and adipose tissue inflammation in diabetic mice. J. Appl. Phycol., 2013, 25(2), 687-693.
350. Maeda, H.; Hosokawa, M.; Sashima, T.; Murakami-Funayama, K.; Miyashita, K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Rep., 2009, 2(6), 897-902.
351. Maeda, H. Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: a review. J. Oleo Sci., 2015, 64(2), 125-132.
352. Uchiyama, K.; Naito, Y.; Hasegawa, G.; Nakamura, N.; Takahashi, J.; Yoshikawa, T. Astaxanthin protects β-cells against glucose toxicity in diabetic db/db mice. Redox Rep., 2002, 7(5), 290-293.
353. Otton, R.; Marin, D.P.; Bolin, A.P.; dos Santos, R.D.C.M.; Polotow, T.G.; Sampaio, S.C.; de Barros, M.P. Astaxanthin ameliorates the redox imbalance in lymphocytes of experimental diabetic rats. Chem. Biol. Interact., 2010, 186(3), 306-315.
354. Hussein, G.; Nakagawa, T.; Goto, H.; Shimada, Y.; Matsumoto, K.; Sankawa, U.; Watanabe, H. Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sci., 2007, 80(6), 522-529.
355. Bhuvaneswari, S.; Arunkumar, E.; Viswanathan, P.; Anuradha, C.V. Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet. Process Biochem., 2010, 45(8), 1406-1414.
356. Bhuvaneswari, S.; Anuradha, C.V. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can. J. Physiol. Pharmacol., 2012, 90(11), 1544-1552.
357. Jono, T.; Miyazaki, A.; Nagai, R.; Sawamura, T.; Kitamura, T.; Horiuchi, S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett., 2002, 511(1), 170-174.
358. Forbes, J.M.; Yee, L.T.L.; Thallas, V.; Lassila, M.; Candido, R.; Jandeleit-Dahm, K.A.; Allen, T.J. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes, 2004, 53(7), 1813-1823.
359. Ahmed, N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pr., 2005, 67(1), 3-21.
360. Stitt, A.W.; McGoldrick, C.; Rice-McCaldin, A.; McCance, D.R.; Glenn, J.V.; Hsu, D.K.; Gardiner, T.A. Impaired retinal angiogenesis in diabetes: Role of advanced glycation end products and Galectin-3. Diabetes, 2005, 54(3), 785-794.
361. Yamamoto, N.; Ozaki, N.; Murakami, K. Trypan-blue-and endoillumination-assisted phacoemulsification in eyes with vitreous hemorrhage during combined cataract and vitreous surgery. Ophthalmologica, 2005, 219(6), 338-344.
362. Reddy, V.P.; Beyaz, A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov. Today, 2006, 11(13), 646-654.
363. Kawanishi, K.; Ueda, H.; Moriyasu, M. Aldose reductase inhibitors from the nature. Curr. Med. Chem., 2003, 10(15), 1353-1374.
364. Manzanaro, S.; Salvá, J.; de la Fuente, J.Á. Phenolic marine natural products as aldose reductase inhibitors. J. Nat. Prod., 2006, 69(10), 1485-1487.
365. Sun, Z.; Peng, X.; Liu, J.; Fan, K.W.; Wang, M.; Chen, F. Inhibitory effects of microalgal extracts on the formation of advanced glycation endproducts (AGEs). Food Chem., 2010, 120(1), 261-267.
366. Sun, Z.; Liu, J.; Zeng, X.; Huangfu, J.; Jiang, Y.; Wang, M.; Chen, F. Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food Function, 2011, 2(5), 251-258.
367. Ulmann, L.; Blanckaert, V.; Mimouni, V.; Andersson, M.X.; Schoefs, B.; Chénais B. Plastid-derived fatty acids and lipids and their implication in health and disease. Mini-Rev. Med. Chem. doi:10.2174/1389557516666160722132736.
368. Kowluru, R.A.; Menon, B.; Gierhart, D.L. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Investig. Ophthalmol. Visual Sci., 2008, 49(4), 1645-1651.
369. Naito, Y.; Uchiyama, K.; Aoi, W.; Hasegawa, G.; Nakamura, N.; Yoshida, N.; Yoshikawa, T. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors, 2004, 20(1), 49-59.
370. Manabe, E.; Handa, O.; Naito, Y.; Mizushima, K.; Akagiri, S.; Adachi, S.; Yoshikawa, T. Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling. J. Cell. Biochem., 2008, 103(6), 1925-1937.
371. Marin, D.P.; Bolin, A.P.; Macedo, R.D.C.S.; Sampaio, S.C.; Otton, R. ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin. Int. Immunopharmacol., 2011, 11(1), 103-109.
372. Kim, Y.J.; Kim, Y.A.; Yokozawa, T. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J. Agric. Food Chem., 2009, 57(19), 8793-8797.
373. Chan, K.C.; Pen, P.J.; Yin, M.C. Anticoagulatory and antiinflammatory effects of astaxanthin in diabetic rats. J. Food Sci., 2012, 77(2), H76-H80.
374. Maeda, K.; Cao, H.; Kono, K.; Gorgun, C.Z.; Furuhashi, M.; Uysal, K.T.; Hotamisligil, G.S. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab., 2005, 1(2), 107-119.
375. Maeda, H.; Hosokawa, M.; Sashima, T.; Miyashita, K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/ diabetic KK-A’ mice. J. Agric. Food Chem., 2007, 55, 7701-7706.
376. Lee, J.; Li, Y.; Li, C.; Li, D. Natural products and body weight control. North Am. J. Med. Sci., 2011, 3(1), 13-19.
377. Ikeuchi, M.; Koyama, T.; Takahashi, J.; Yazawa, K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci. Biotechnol. Biochem., 2007, 71(4), 893-899.
378. Ikeuchi, M.; Koyama, T.; Takahashi, J.; Yazawa, K. Effects of astaxanthin supplementation on exercise-induced fatigue in mice. Biol. Pharmaceut. Bull., 2006, 29(10), 2106-2110.
379. Arunkumar, E.; Bhuvaneswari, S.; Anuradha, C.V. An intervention study in obese mice with astaxanthin, a marine carotenoid -effects on insulin signaling and pro-inflammatory cytokines. Food Funct., 2012, 3(2), 120-126.
380. Gammone, M.A.; D’Orazio, N.; Anti-obesity activity of the marine carotenoid fucoxanthin. Mar. Drugs, 2015, 13, 2196-2214.
381. Maeda, H.; Hosokawa, M.; Sashima, T.; Funayama, K.; Miyashita, K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem. Biophys. Res. Commun., 2005, 332, 392-397.
382. Maeda, H.; Hosokawa, M.; Sashima, T.; Funayama, K.; Miyashita, K. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J. Oleo Sci., 2007, 56(12), 615-621.
383. Krinsky, N.I.; Landrum, J.T.; Bone, R.A. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr., 2003, 23(1), 171-201.
384. Jacques P.F. The potential preventive effects of vitamins for cataract and age-related macular degeneration. Int. J. Vitamin Nutr. Res., 1999, 69(3), 198-205.
385. Lyle, B.J.; Mares-Perlman, J.A.; Klein, B.E.; Klein, R.; Palta, M.; Bowen, P.E.; Greger, J.L. Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. Am. J. Clin. Nutr., 1999, 69(2), 272-277.
386. Seddon, J.M.; Ajani, U.A.; Sperduto, R.D.; Hiller, R.; Blair, N.; Burton, T.C.; Willett, W. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA J. Am. Med. Assoc., 1994, 272(18), 1413-1420.
387. Karppi, J.; Laukkanen, J.A.; Kurl, S. Plasma lutein and zeaxanthin and the risk of age-related nuclear cataract among the elderly Finnish population. Br. J. Nutr., 2012, 108(1), 148-154.
388. Junghans, A.; Sies, H.; Stahl, W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch. Biochem. Biophys., 2001, 391(2), 160-164.
389. Zhao, L.; Sweet, B.V. Lutein and zeaxanthin for macular degeneration. Am. J. Health Syst. Pharm., 2008, 65(13), 1232-1238.
390. Bone, R.A.; Landrum, J.T.; Mayne, S.T.; Gomez, C.M.; Tibor, S.E.; Twaroska, E.E. Macular pigment in donor eyes with and without AMD: A case-control study. Invest. Ophthalmol. Visual Sci., 2001, 42(1), 235-240.
391. Richer, S.; Stiles, W.; Statkute, L.; Pulido, J.; Frankowski, J.; Rudy, D.; Nyland, J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry, 2004, 75(4), 216-229.
392. O'Connor, I.; O'Brien, N. Modulation of UVA light-induced oxidative stress by β-carotene, lutein and astaxanthin in cultured fibroblasts. J. Dermat. Sci., 1998, 16(3), 226-230.
393. Tso, M.O.M.; Lam, T.T. Method of retarding and ameliorating central nervous system and eye damage. U.S. Patent 5,527,533, June 18, 1996.
394. Sawaki, K.; Yoshigi, H.; Aoki, K.; Koikawa, N.; Azumane, A.; Kaneko, K.; Yamaguchi, M. Sports performance benefits from taking natural astaxanthin characterized by visual activity and muscle fatigue improvements in humans. J. Clin. Ther. Med., 2002, 18(9), 73-88.
395. Nagaki, Y.; Mihara, M.; Tsukahara, H.; Ono, S. The supplementation effect of astaxanthin on accommodation and asthenopia. J. Clin. Ther. Med., 2006, 22(1), 41-54.
396. Izumi-Nagai, K.; Nagai, N.; Ohgami, K.; Satofuka, S.; Ozawa, Y.; Tsubota, K.; Ishida, S. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Investig. Ophthalmol. Visual Sci., 2008, 49(4), 1679-1685.
397. Ohgami, K.; Shiratori, K.; Kotake, S.; Nishida, T.; Mizuki, N.; Yazawa, K.; Ohno, S. Effects of astaxanthin on lipopolysaccharideinduced inflammation in vitro and in vivo. Invest. Ophthalmol. Visual Sci., 2003, 44(6), 2694-2701.
398. Suzuki, Y.; Ohgami, K.; Shiratori, K.; Jin, X.H.; Ilieva, I.; Koyama, Y.; Ohno, S. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-κB signaling pathway. Exp. Eye Res., 2006, 82(2), 275-281.
399. Shiratori, K.; Ohgami, K.; Ilieva, I.; Jin, X.H.; Koyama, Y.; Miyashita, K.; Ohno, S. Effects of fucoxanthin on lipopolysaccharideinduced inflammation in vitro and in vivo. Exp. Eye Res., 2005, 81(4), 422-428.
400. Cort, A.; Ozturk, N.; Akpinar, D.; Unal, M.; Yucel, G.; Ciftcioglu, A.; Aslan, M. Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul. Toxicol. Pharmacol., 2010, 58(1), 121-130.
401. Tsai, C.F.; Lu, F.J.; Hsu, Y.W. Protective effects of Dunaliella salina -a carotenoids-rich alga -against ultraviolet B-induced corneal oxidative damage in mice. Mol. Vis., 2012, 18, 1540-1547.
402. Lyons, N.M.; O'Brien, N.M. Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture. J. Dermatol. Sci., 2002, 30(1), 73-84.
403. Camera, E.; Mastrofrancesco, A.; Fabbri, C.; Daubrawa, F.; Picardo, M.; Sies, H.; Stahl, W. Astaxanthin, canthaxanthin and β-carotene differently affect UVA-induced oxidative damage and expression of oxidative stress-responsive enzymes. Exp. Dermatol., 2009, 18(3), 222-231.
404. Suganuma, K.; Nakajima, H.; Ohtsuki, M.; Imokawa, G. Astaxanthin attenuates the UVA-induced up-regulation of matrixmetalloproteinase-1 and skin fibroblast elastase in human dermal fibroblasts. J. Dermatol. Sci., 2010, 58(2), 136-142.
405. Stahl, W.; Heinrich, U.; Jungmann, H.; Sies, H.; Tronnier, H. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am. J. Clin. Nutr., 2000, 71(3), 795-798.
406. Stahl, W.; Heinrich, U.; Wiseman, S.; Eichler, O.; Sies, H.; Tronnier, H. Dietary tomato paste protects against ultraviolet lightinduced erythema in humans. J. Nutr., 2001, 131(5), 1449-1451.
407. Sourkes, T.L. The discovery and early history of carotene. Bull. Hist. Chem., 2009, 34(1), 32-38.
408. Inhoffen, H.H.; Pommer, H.; Bohlmann, F.; Synthesen in der Carotinoid-reihe, XIV. Aufbau des β-Carotins. Liebigs Ann. Chem., 1950, 569, 237-246.
409. Inhoffen, H.H.; Pommer, H., Westphal, F. Synthesen in der Carotinoid-reihe, XVI. Eine weitere Synthese des β-Carotins. Liebigs Ann. Chem., 1950, 570, 69-72.
410. Code of Federal Regulations, 2011. 21 CFR Part 70: Color additives; Part 71: Color additive petitions; Part 73: Color additives exempt from certification; Part 74: Color additives subject to certification; Part 80: Color additive certification; Part 81: General specifications and general restrictions for provisional color additives; Part 82: Certified provisionally listed colors and specifications. U.S. Food and Drug Administration, Washington, DC. http://www.fda.gov/ForIndustry/ColorAdditives/default.htm (accessed 25.04.14).
411. Wrolstad, R.E.; Culver, C.A. Alternatives to those artificial FD&C food colorants. Annu. Rev. Food Sci. Technol., 2012, 3, 59-77.
412. Mercadante, A.Z.; Rodriguez-Amaya, D.B. Effects of ripening, cultivar differences, and processing on the carotenoid composition of mango. J. Agric. Food Chem., 1998, 46, 128-130.
413. Coultate, T.P. Food: The Chemistry of its Components, 3rd ed.; Royal Society of Chemistry: Cambridge, 1996.
414. Alija, A.J.; Bresgen, N.; Sommerburg, O.; Siems, W.; Eckl, P.M. Cytotoxic and genotoxic effects of β-carotene breakdown products on primary rat hepatocytes. Carcinogenesis, 2004, 25(5), 827-831.
415. Khoo, H.-E.; Prasad, K.N.; Kong, K.-W.; Jiang, Y.; Ismail, A. Carotenoids and their isomers: Color pigments in fruits and vegetables. Molecules, 2011, 16, 1710-1738.
416. Report of the Joint FAO/WHO Expert Committee on Food Additives. Evaluation of Certain Food Additives and Contaminants; 57th. WHO, Geneva, Switzerland, pp. 909, 2002.
417. Ben-Amotz, A. In: Enigmatic Microorganisms and Life in Extreme Environments; Seckbach, J., Ed.; Springer: Dordrecht, 1999; pp. 401-410.
418. Cooper, R.D.G.; Davis, J.B.; Leftwick, A.P.; Price, C.; Weedon, B. Carotenoids and related compounds. XXXII. Synthesis of astaxanthin, hoenicoxanthin, hydroxyechinenone, and the corresponding diosphenols. J. Chem. Soc. Perkin Trans. 1975, 1(21), 2195-2204.
419. Yuan, J.P.; Peng, J.; Yin, K.; Wang, J.H. Potential healthpromoting effects of astaxanthin: A high-value carotenoid mostly from microalgae. Mol. Nutr. Food Res., 2011, 55, 150-165.
420. van Wijk, A.A.C.; Spaans, A.; Uzunbajakava, N., Otto, C.; de Groot, H.J.M.; Lugtenburg, J.; Buda, F. Spectroscopy and quantum chemical modeling reveal a predominant contribution of excitonic interactions to the bathochromic shift in α-crustacyanin, the blue carotenoprotein in the carapace of the lobster Homarus gammarus. J. Am. Chem. Soc., 2005, 127(5), 1438-1445.
421. Lorenz, R.T.; Cysewski, G.R. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol., 2000, 18, 160-167.
422. Lubbe, A.; Verpoorte, R. Cultivation of medicinal and aromatic plants for specialty industrial materials. Ind. Crop. Prod., 2011, 34, 785-801.
423. Lemoine, Y.; Rmiki, N.-E.; Créach, A.; Rachidi, J.; Schoefs, B. In: Plant Cell Compartments -Selected Topics; Schoefs, B., Ed.; Research Signpost: Trivandrum, 2008; pp. 251-284.
424. Frey, D.A.; Kataisto, E.W.; Ekmanis, J.L.; O’Malley, S.; Lockwood, S.F. The efficient synthesis of disodium dissucinate astaxanthin (Cardax). Org. Process Res. Dev., 2004, 8, 796-801.
425. Cardounel, A.J.; Dumitrescu, C.; Zweier, J.L.; Lockwood, S.F. Direct superoxide anion scavenging by a sodium disuccinate astaxanthin derivative: Relative efficacy of individual stereoisomers versus the statistical mixture of stereoisomers by electron paramagnetic resonance imaging. Biochem. Biophys. Res. Commun., 2003, 307(3), 706-712.
426. Zsila, F.; Simonyi, M.; Lockwood, S.F. Interaction of the disodium disuccinate derivative of meso-astaxanthin with human serum albumin: From chiral complexation to self-assembly. Bioorg. Med. Chem. Lett., 2003, 13, 1093-1100.
427. Gross, G.J.; Lockwood, S.F. Acute and chronic administration of disodium disuccinate astaxanthin (CardaxTM) produces marked cardioprotection in dog hearts. Mol. Cell. Biochem., 2005, 272, 221-227.
428. Kim, S.H.; Kim, J.H.; Lee, B.Y.; Lee, P.C. The astaxanthin dideoxyglucoside biosynthesis pathway in Sphingomonas sp. PB304. Appl. Microbiol. Biotechnol., 2014, 98, 9983-10003.
429. Asker, D.; Amano, S.I.; Morita, K.; Tamura, K.; Sakud, S.; Kikuchi, N.; Furihata, K.; Matsufuji, H.; Beppu, T.; Ueda, K. Astaxanthin dirhamnoside, a new astaxanthin produced by a radiotolerant bacterium, Sphingomonas astaxanthinifaciens. J. Antibiot., 2009, 62(7), 397-399.
430. Metting, F.B. Biodiversity and application of microalgae. J. Ind. Microbiol., 1996, 17, 477-489.
431. Ramesha, B.T.; Gertsch, J.; Ravikanth, G.; Priti, V.; Ganeshaiah, K.N.; Shaanker, R.U. Biodiversity and chemodiversity: Future perspectives in bioprospecting. Curr. Drug Targets, 2011, 12, 1515-1530.
432. Deli, J.; Gonda, S.; Nagy, L.Z.; Szabó, I.; Gulyás-Fekete, G.; Agocs, A.; Marton, K.; Vasas, G. Carotenoid composition of three bloom-forming alga species. Food Res. Int., 2014, 65, 215-223.
433. Nishino, H.; Murokoshi, M.; Tokuda, H.; Satomi, Y. Cancer prevention by carotenoids. Arch. Biochem. Biophys., 2009, 482, 163-168.
434. Chang, J.J.; Thia, C.; Lin, H.Y.; Liu, H.L.; Ho, F.J.; Wu, J.T.; Shih, M.C.; Li, W.H.; Li, W.H.; Huang, C.C. Integrating an algal β-carotene hydroxylase gene into a designed carotenoid-biosynthesis pathway increases carotenoid production in yeast. Bioresource Technol., 2015, 184, 2-8.
435. Scaife, M.A.; Burja, A.M.; Wright, P.C. Characterization of cyanobacterial β-carotene ketolase and hydroxylase genes in Escherichia coli, and their application for astaxanthin biosynthesis. Biotechnol. Bioeng., 2009, 103(5), 944-955.
436. Niu, J.-F.; Wang, G.-C.; Lin, X.; Zhou, B.-C. Large-scale recovery of C-phycocyanin from Spirulina platensis using expanded bed adsorption chromatography. J. Chromatogr. B., 2007, 850(1-2), 267-276.
437. Mysliwa-Kurdziel, B., Solymosi, K. Phycobilins and phycobiliproteins used in food industry and medicine. Mini-Rev. Med. Chem., 2017, 17(13), 1173-1193.
438. Solymosi, K., Mysliwa-Kurdziel, B. Chlorophylls and their derivatives used in food industry and medicine. Mini-Rev. Med. Chem., 2017, 17(13), 1194-1222.